Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kerry Lynn Reynolds, M.D.

Co-Author

This page shows the publications co-authored by Kerry Reynolds and Leah Thompson.
Connection Strength

0.705
  1. Patterns of Cutaneous and Noncutaneous Immune-Related Adverse Events Among Patients With Advanced Cancer. JAMA Dermatol. 2021 05 01; 157(5):577-582.
    View in: PubMed
    Score: 0.234
  2. Impact of systemic corticosteroids on survival outcomes in immune checkpoint inhibitor-induced gastroenterocolitis. Eur J Cancer. 2021 01; 142:143-146.
    View in: PubMed
    Score: 0.225
  3. Association of preexisting drug allergies with cutaneous immune related adverse events among patients on immune checkpoint inhibitor therapy. Br J Dermatol. 2022 Mar 15.
    View in: PubMed
    Score: 0.062
  4. Evaluating the treatment of cutaneous adverse events and adherence to National Comprehensive Cancer Network guidelines in patients receiving immune checkpoint inhibitors. Eur J Cancer. 2022 Mar 05; 166:21-23.
    View in: PubMed
    Score: 0.062
  5. Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma. J Am Acad Dermatol. 2022 Feb 19.
    View in: PubMed
    Score: 0.062
  6. Methotrexate in the treatment of immune checkpoint blocker-induced bullous pemphigoid. Eur J Cancer. 2021 12; 159:34-37.
    View in: PubMed
    Score: 0.060
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.